Physician profile
Phoebe E Koch
NPI 1194907741
$2,029.84
in general payments reported to CMS, 2019-2025
22 companies · $92.84 in 2025
The $92.84 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $232 · 2021: $558 · 2022: $357 · 2023: $223 · 2024: $259 · 2025: $92.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $574.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $958.56 | 2019-2025 | |
| Pfizer INC. | $224.31 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $168.72 | 2022-2024 | Sotyktu |
| Genzyme Corporation | $120.84 | 2020-2024 | |
| Leo Pharma INC. | $77.87 | 2025 | Adbry |
| Prugen, INC. Pharmaceuticals | $77.30 | 2019-2020 | |
| Kyowa Kirin, INC. | $59.52 | 2020-2021 | |
| Amgen INC. | $49.50 | 2021-2023 | Otezla |
| Ucb, INC. | $41.18 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $32.88 | 2021 | |
| Allergan, INC. | $29.54 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $23.89 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.63 | 2024 | Spevigo |
| Sun Pharmaceutical Industries INC. | $18.90 | 2019 | |
| Janssen Biotech, INC. | $18.40 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $18.05 | 2024 | Taltz, Olumiant |
| Galderma Laboratories, L.P. | $17.11 | 2024 | |
| Biofrontera INC. | $16.01 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $15.11 | 2019 | |
| Incyte Corporation | $13.22 | 2021 | |
| Genentech USA, INC. | $13.20 | 2021 | |
| Organogenesis INC. | $13.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phoebe Koch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.